Latest / Something More with Chris Boyd
Brandon Monk, Head of U.S. Plasma Derived Therapies, Takeda Pharmaceuticals
Brandon Monk, Head of U.S. Plasma Derived Therapies at Takeda Pharmaceuticals, talks about immunizations for and treatment of Covid-19. Takeda is working on a hyperimmune plasma therapy and is a part of the CoVig-19 Plasma Alliance, consisting of top R&D leaders working together for treatment of Covid-19. #financialplanning #retirementreadiness
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.